Antimicrobial microneedle patch for treating deep cutaneous fungal infection

Subcutaneous fungal infection is often difficult to be treated by the conventional topical application or oral intake of antifungal agents because of low drug bioavailability to the infection site, lack of sustained therapeutic effect, and development of drug resistance. Here, a new strategy using p...

Full description

Saved in:
Bibliographic Details
Main Authors: Zan, Ping, Than, Aung, Duong, Phan Khanh, Song, Juha, Xu, Chuanhui, Chen, Peng
Other Authors: School of Chemical and Biomedical Engineering
Format: Article
Language:English
Published: 2021
Subjects:
Online Access:https://hdl.handle.net/10356/147531
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-147531
record_format dspace
spelling sg-ntu-dr.10356-1475312023-12-29T06:49:29Z Antimicrobial microneedle patch for treating deep cutaneous fungal infection Zan, Ping Than, Aung Duong, Phan Khanh Song, Juha Xu, Chuanhui Chen, Peng School of Chemical and Biomedical Engineering Innovative Centre for Flexible Devices Engineering Microneedles Fungal Infection Subcutaneous fungal infection is often difficult to be treated by the conventional topical application or oral intake of antifungal agents because of low drug bioavailability to the infection site, lack of sustained therapeutic effect, and development of drug resistance. Here, a new strategy using polymeric microneedle (MN) patches to overcome the skin barrier is reported. MN is made of a biocompatible and biodegradable chitosan–polyethylenimine copolymer, which possesses antimicrobial property immune to drug resistance and allows sustained drug release. Using a fungal infection mouse model, it is demonstrated that MN patches encapsulated with antifungal agent amphotericin B offer outstanding treatment effectiveness. It is attributable to the high bioavailability of therapeutics and synergistic actions of the antifungal polymer and drug. Ministry of Education (MOE) This research was supported by Ministry of Education - Singapore (MOE AcRF Tier 1: RG52/17). 2021-04-06T07:38:23Z 2021-04-06T07:38:23Z 2019 Journal Article Zan, P., Than, A., Duong, P. K., Song, J., Xu, C. & Chen, P. (2019). Antimicrobial microneedle patch for treating deep cutaneous fungal infection. Advanced Therapeutics, 2(10), 1900064-. https://dx.doi.org/10.1002/adtp.201900064 2366-3987 https://hdl.handle.net/10356/147531 10.1002/adtp.201900064 10 2 1900064 en Advanced Therapeutics 10.21979/N9/96LHKL This is the peer reviewed version of the following article: Zan, P., Than, A., Duong, P. K., Song, J., Xu, C. & Chen, P. (2019). Antimicrobial microneedle patch for treating deep cutaneous fungal infection. Advanced Therapeutics, 2(10), 1900064-. https://dx.doi.org/10.1002/adtp.201900064, which has been published in final form at https://doi.org/10.1002/adtp.201900064. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Engineering
Microneedles
Fungal Infection
spellingShingle Engineering
Microneedles
Fungal Infection
Zan, Ping
Than, Aung
Duong, Phan Khanh
Song, Juha
Xu, Chuanhui
Chen, Peng
Antimicrobial microneedle patch for treating deep cutaneous fungal infection
description Subcutaneous fungal infection is often difficult to be treated by the conventional topical application or oral intake of antifungal agents because of low drug bioavailability to the infection site, lack of sustained therapeutic effect, and development of drug resistance. Here, a new strategy using polymeric microneedle (MN) patches to overcome the skin barrier is reported. MN is made of a biocompatible and biodegradable chitosan–polyethylenimine copolymer, which possesses antimicrobial property immune to drug resistance and allows sustained drug release. Using a fungal infection mouse model, it is demonstrated that MN patches encapsulated with antifungal agent amphotericin B offer outstanding treatment effectiveness. It is attributable to the high bioavailability of therapeutics and synergistic actions of the antifungal polymer and drug.
author2 School of Chemical and Biomedical Engineering
author_facet School of Chemical and Biomedical Engineering
Zan, Ping
Than, Aung
Duong, Phan Khanh
Song, Juha
Xu, Chuanhui
Chen, Peng
format Article
author Zan, Ping
Than, Aung
Duong, Phan Khanh
Song, Juha
Xu, Chuanhui
Chen, Peng
author_sort Zan, Ping
title Antimicrobial microneedle patch for treating deep cutaneous fungal infection
title_short Antimicrobial microneedle patch for treating deep cutaneous fungal infection
title_full Antimicrobial microneedle patch for treating deep cutaneous fungal infection
title_fullStr Antimicrobial microneedle patch for treating deep cutaneous fungal infection
title_full_unstemmed Antimicrobial microneedle patch for treating deep cutaneous fungal infection
title_sort antimicrobial microneedle patch for treating deep cutaneous fungal infection
publishDate 2021
url https://hdl.handle.net/10356/147531
_version_ 1787136611967827968